Trademarkia Logo

Australia

AU$
Trademark Search
LERAVIC

View On IPO.GOV.AU

LERAVIC
Cancelled: Cancelled at the request of IB

Last updated on 24 May 2023

Owner Info

Tobira Therapeutics, Inc.

5 Giralda Farms

Madison NJ 07940, UNITED STATES OF AMERICA

Serial Number

2138791 filed on 14 Oct 2020

Correspondent

Baker & McKenzie LLP

100 New Bridge Street,

London EC4V 6JA,

UNITED KINGDOM

LERAVIC

Classification Information

Class [005]
Pharmaceutical preparations for the treatment and prevention of gastro-intestinal diseases and disorders.

Mark Details

Serial Number

2138791

Registered On

14 Oct 2020

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)

Date

23 Apr 2020

Mark Type

US

Legal History

Show more

Status DateAction Taken
24th May 2023Status change to Voided
16th Feb 2021International Registration in Australia Protected correspondence sent
15th Feb 2021IP Right Registration Published
15th Feb 2021Status change to Registered/Protected
14th Jan 2021Amendment to International Registration Contact Requested
8th Dec 2020Application Accepted correspondence sent
7th Dec 2020IP Right has been Examined
7th Dec 2020IP Right Acceptance Published
7th Dec 2020Status change to Accepted
27th Nov 2020Awaiting examination